Graves’ disease post-COVID-19 m-RNA vaccine in pediatric age group
The surge of the COVID-19 pandemic (December / 2019 - May/2023) and its catastrophic effect worldwide have necessitated emergent intervention to reduce its influence on people's health and life. To eliminate and reduce the impact of COVID-19 infection, COVID-19 vaccination was emergently author...
Main Authors: | Abhaa Al-Jahhafi, Asma Al-Sawaai, Zamzam Al-Bimani, Naima Khamis Al bulushi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2024-01-01
|
Series: | Asia Oceania Journal of Nuclear Medicine and Biology |
Subjects: | |
Online Access: | https://aojnmb.mums.ac.ir/article_23251_546bbb98bb0a786ca4cb493956e441ea.pdf |
Similar Items
-
Psychological aspects of Graves’ ophthalmopathy
by: Waleed K W Al-Badri, et al.
Published: (2024-08-01) -
Anti-thyroid drugs in pediatric Graves′ disease
by: Mathew John, et al.
Published: (2015-01-01) -
Selenium and Graves’ Disease
by: Vahab Fatourechi, et al.
Published: (2024-10-01) -
Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01) -
Thyroid Receptor Antibody and the Development of Graves’ Orbitopathy: Clinical Experience of using Radioiodine Ablation in the Management of Graves’ Orbitopathy in post-iodine ablation hypothyroid patient
by: Edelyn Christina, et al.
Published: (2023-06-01)